Recent Updates
Recently added Catalysts
AORT Positive Sentiment Score: 70/100

Artivion Announces Release Date and Teleconference Call Details for Third Quarter 2023 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023...

Key Takeaway: Artivion, Inc. has announced its third quarter 2023 financial results will be released on November 2, 2023, after market close. The company will hold a teleconference and live webcast at 4:30 p.m. ET to discuss the results, with a question and answer session led by CEO Pat Mackin. Interested parties can access the teleconference and webcast through the company's website and designated phone lines.

Market Sentiment Analysis

POSITIVE FACTORS

  • Announcement of upcoming financial results suggests transparency.
  • Teleconference provides an opportunity for direct engagement with stakeholders.
  • Quarterly results may show positive performance reflecting growth in aortic disease treatment.

Full Press Release Details

ATLANTA , Oct. 19, 2023 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that third quarter 2023 financial results will be released on Thursday, November 2, 2023 after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question and answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13741667.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc. Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
Contacts:
Artivion D. Ashley Lee Executive Vice President & Chief Financial Officer Phone: 770-419-3355 Gilmartin Group LLC Brian Johnston / Lynn Lewis Phone: 332-895-3222 [email protected]
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its Q3 2023 financial results?

Artivion will release its Q3 2023 financial results on November 2, 2023.

What time is the Artivion teleconference on November 2?

The teleconference will start at 4:30 p.m. ET on November 2, 2023.

How can I access the teleconference replay?

The teleconference replay can be accessed by calling 877-660-6853 or 201-612-7415.

Where can I find Artivion's financial press release?

The earnings press release will be available on Artivion's Investors section of their website.

What products does Artivion specialize in?

Artivion specializes in aortic stent grafts, surgical sealants, and On-X heart valves.

Last updated: Oct 19, 2023